Updates matching "Remove Hurdles to Cancer Care"

April 26, 2022

Legislation introduced in the U.S. House of Representatives today aims to improve access to quality health care for and decrease health disparities in communities of color.

April 15, 2022

Governor Tony Evers vetoed two bills that would have tightened access to health care coverage for limited-income Wisconsinites. Senate Bill 905/Assembly Bill 934 aimed to require Medicaid enrollees to prove eligibility and re-apply every six months. Senate Bill 912/Assembly Bill 936 would have added new work rules to the program,

April 5, 2022

ACS CAN volunteers met virtually with state lawmakers and urged them to pass legislation that would ensure comprehensive biomarker testing is covered by more insurance plans. Biomarker testing is critical in accessing precision medicine, which can lead to improved survivorship and better quality of life for cancer patients.

March 31, 2022

COLUMBUS, OHIO – After two years of virtual Cancer Action Days due to the pandemic, cancer patients, survivors and caregivers from across the state traveled to the Capitol in Columbus yesterday to meet in person with their elected officials. They let their lawmakers know that they can and must do

March 9, 2022

The 2021-22 Wisconsin legislative session ended this week. This session was marked by important wins for cancer prevention and early detection, as well as battles against unwarranted efforts to create barriers to accessing care.

March 8, 2022
New York

ACS CAN is joined by more than 65 organizations asking for colorectal screening to be included in the budget.

March 8, 2022
New Jersey

As Gov, Murphy releases budget, ACS CAN highlights priorities

February 24, 2022

The Kansas legislature left Topeka without adequately addressing several critical issues affecting access to health care for tens of thousands of Kansans, particularly those in need of cancer screening and treatment.

February 24, 2022

The House of Representatives passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. House Bill 2144 aims to enable more Arizonans to benefit from biomarker testing, a critical step in accessing precision medicine treatments.